Clinical Trial Results: Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin in metastatic prostate cancer with homologous recombination pathway gene alterations completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Metastasis

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Castration-resistant Prostate Cancer, Metastasis | Phase 2 | Status: COMPLETED | Results posted: 2026-06-11